259 related articles for article (PubMed ID: 11561757)
1. Gsalpha gene mutations in monostotic fibrous dysplasia of bone and fibrous dysplasia-like low-grade central osteosarcoma.
Pollandt K; Engels C; Kaiser E; Werner M; Delling G
Virchows Arch; 2001 Aug; 439(2):170-5. PubMed ID: 11561757
[TBL] [Abstract][Full Text] [Related]
2. Activating GNAS mutations in parosteal osteosarcoma.
Carter JM; Inwards CY; Jin L; Evers B; Wenger DE; Oliveira AM; Fritchie KJ
Am J Surg Pathol; 2014 Mar; 38(3):402-9. PubMed ID: 24525511
[TBL] [Abstract][Full Text] [Related]
3. Osteosarcoma arising in fibrous dysplasia, confirmed by mutational analysis of GNAS gene.
Sugiura Y; Kanda H; Motoi N; Nomura K; Inamura K; Okada E; Matsumoto H; Shimoji T; Matsumoto S; Nakayama J; Takazawa Y; Ishikawa Y; Machinami R
Pathol Res Pract; 2018 Feb; 214(2):318-324. PubMed ID: 29268950
[TBL] [Abstract][Full Text] [Related]
4. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gsalpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues.
Sakamoto A; Oda Y; Iwamoto Y; Tsuneyoshi M
J Mol Diagn; 2000 May; 2(2):67-72. PubMed ID: 11272890
[TBL] [Abstract][Full Text] [Related]
5. Activating mutations of Gs protein in monostotic fibrous lesions of bone.
Alman BA; Greel DA; Wolfe HJ
J Orthop Res; 1996 Mar; 14(2):311-5. PubMed ID: 8648511
[TBL] [Abstract][Full Text] [Related]
6. [Abnormal expression of c-myc, p53, p16 protein and GNAS1 gene mutation in fibrous dysplasia].
Tang J; Zhao HY; Zheng L; Zhang HZ; Jiang ZM
Zhonghua Bing Li Xue Za Zhi; 2009 May; 38(5):292-7. PubMed ID: 19575869
[TBL] [Abstract][Full Text] [Related]
7. Investigation of the GSalpha gene in the diagnosis of fibrous dysplasia.
Perdigão PF; Pimenta FJ; Castro WH; De Marco L; Gomez RS
Int J Oral Maxillofac Surg; 2004 Jul; 33(5):498-501. PubMed ID: 15183415
[TBL] [Abstract][Full Text] [Related]
8. The diagnostic utility of the GNAS mutation in patients with fibrous dysplasia: meta-analysis of 168 sporadic cases.
Lee SE; Lee EH; Park H; Sung JY; Lee HW; Kang SY; Seo S; Kim BH; Lee H; Seo AN; Ahn G; Choi YL
Hum Pathol; 2012 Aug; 43(8):1234-42. PubMed ID: 22245114
[TBL] [Abstract][Full Text] [Related]
9. Osteoblast-specific expression of the fibrous dysplasia (FD)-causing mutation Gsα(R201C) produces a high bone mass phenotype but does not reproduce FD in the mouse.
Remoli C; Michienzi S; Sacchetti B; Consiglio AD; Cersosimo S; Spica E; Robey PG; Holmbeck K; Cumano A; Boyde A; Davis G; Saggio I; Riminucci M; Bianco P
J Bone Miner Res; 2015 Jun; 30(6):1030-43. PubMed ID: 25487351
[TBL] [Abstract][Full Text] [Related]
10. A sensitive mutation-specific screening technique for GNAS1 mutations in cases of fibrous dysplasia: the first report of a codon 227 mutation in bone.
Idowu BD; Al-Adnani M; O'Donnell P; Yu L; Odell E; Diss T; Gale RE; Flanagan AM
Histopathology; 2007 May; 50(6):691-704. PubMed ID: 17493233
[TBL] [Abstract][Full Text] [Related]
11. Activating Gs a mutation rarely occurs in musculoskeletal tumors other than fibrous dysplasia.
Gu W; Ogose A; Matsuba A; Kawashima H; Hotta T; Kudo N; Hoshino M; Kondo N; Mera H; Endo N
Anticancer Res; 2006; 26(2B):1611-4. PubMed ID: 16619580
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoids decrease interleukin-6 levels and induce mineralization of cultured osteogenic cells from children with fibrous dysplasia.
Stanton RP; Hobson GM; Montgomery BE; Moses PA; Smith-Kirwin SM; Funanage VL
J Bone Miner Res; 1999 Jul; 14(7):1104-14. PubMed ID: 10404010
[TBL] [Abstract][Full Text] [Related]
13. The histopathology of fibrous dysplasia of bone in patients with activating mutations of the Gs alpha gene: site-specific patterns and recurrent histological hallmarks.
Riminucci M; Liu B; Corsi A; Shenker A; Spiegel AM; Robey PG; Bianco P
J Pathol; 1999 Jan; 187(2):249-58. PubMed ID: 10365102
[TBL] [Abstract][Full Text] [Related]
14. GNAS mutational analysis in differentiating fibrous dysplasia and ossifying fibroma of the jaw.
Shi RR; Li XF; Zhang R; Chen Y; Li TJ
Mod Pathol; 2013 Aug; 26(8):1023-31. PubMed ID: 23503642
[TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of activating alpha subunit of the G protein (Gsα) mutation by pyrosequencing in fibrous dysplasia and other bone lesions.
Liang Q; Wei M; Hodge L; Fanburg-Smith JC; Nelson A; Miettinen M; Foss RD; Wang G
J Mol Diagn; 2011 Mar; 13(2):137-42. PubMed ID: 21354047
[TBL] [Abstract][Full Text] [Related]
16. Cellular and molecular basis of fibrous dysplasia.
Marie PJ
Histol Histopathol; 2001 Jul; 16(3):981-8. PubMed ID: 11510989
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic value of investigating GNAS mutations in fibro-osseous lesions: a retrospective study of 91 cases of fibrous dysplasia and 40 other fibro-osseous lesions.
Tabareau-Delalande F; Collin C; Gomez-Brouchet A; Decouvelaere AV; Bouvier C; Larousserie F; Marie B; Delfour C; Aubert S; Rosset P; de Muret A; Pagès JC; de Pinieux G
Mod Pathol; 2013 Jul; 26(7):911-21. PubMed ID: 23370769
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of Gsα(R201C) in mice produces a heritable, direct replica of human fibrous dysplasia bone pathology and demonstrates its natural history.
Saggio I; Remoli C; Spica E; Cersosimo S; Sacchetti B; Robey PG; Holmbeck K; Cumano A; Boyde A; Bianco P; Riminucci M
J Bone Miner Res; 2014 Nov; 29(11):2357-68. PubMed ID: 24764158
[TBL] [Abstract][Full Text] [Related]
19. Frequency of GNAS R201H substitution mutation in polyostotic fibrous dysplasia: Pyrosequencing analysis in tissue samples with or without decalcification.
Shin SJ; Lee SJ; Kim SK
Sci Rep; 2017 Jun; 7(1):2836. PubMed ID: 28588314
[TBL] [Abstract][Full Text] [Related]
20. Treatment of craniofacial fibrous dysplasia: a case report.
Carini F; Saggese V; Porcaro G; Baldoni M
Minerva Stomatol; 2014; 63(1-2):43-9. PubMed ID: 24487949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
